Skip to main content

Table 2 Baseline demographic characteristics of the RVO patients and control subjects

From: Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion

 

RVO patients (n = 80)

Control (=80)

p

Age (year)

60.2 ± 12.1

59 ± 12.6

0.54

Female (%)

41 (51.3)

42 (52.5)

0.87

Hypertension (%)

43 (53.8)

22 (27.5)

0.0001*

Diabetes mellitus (%)

31 (38.8)

12 (15.0)

0.001*

Hyperlipidemia (%)

37 (46.3)

24 (30.0)

0.034*

Current smoking (%)

41 (51.3)

25 (31.3)

0.01*

History for CAD (%)

23 (28.8)

17 (21.3)

0.27

BMI (kg/m 2 )

23.4 ± 3.1

23.8 ± 3.3

0.43

  1. *p < 0.05.
  2. Data are presented as mean ± standard deviation or number (%), where appropriate.
  3. RVO, retinal vein occlusion; CAD, coronary artery disease; BMI, body mass index.